Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-cell Transplantation Publication Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem-cell Transplantation CertaraMay 15, 2018
A Randomized, First-in-human, Healthy Volunteer Trial of Sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway Publication A Randomized, First-in-human, Healthy Volunteer Trial of Sutimlimab, a Humanized Antibody for the Specific Inhibition of the Classical Complement Pathway CertaraMay 8, 2018
PharmTeX: A LaTeX-based Open-source Platform for Automated Reporting Workflow Publication PharmTeX: A LaTeX-based Open-source Platform for Automated Reporting Workflow CertaraMay 1, 2018
Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain Publication Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain CertaraMay 1, 2018
Population Pharmacokinetics of Intravenous Linezolid in Premature Infants Publication Population Pharmacokinetics of Intravenous Linezolid in Premature Infants CertaraApril 9, 2018
Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations Publication Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations CertaraApril 1, 2018
Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function Publication Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function CertaraApril 1, 2018
Changing the Game in Drug Development Brochure Changing the Game in Drug Development At Certara, we are innovators, dedicated to helping our clients develop new therapies and target…CertaraMarch 19, 2018
An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Publication An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) CertaraMarch 15, 2018
Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Publication Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics CertaraMarch 1, 2018